SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Arena Pharmaceuticals, Inc. Picks Japan's Eisai Inc. To Market Obesity Drug Lorcaserin In Deal Worth $1.3 Billion Potentially